EME:NYSEEMCOR Group, Inc. Analysis
Data as of 2026-03-31 - not real-time
$723.77
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
EMCOR Group (EME) trades at $723.77, sitting just above its 20‑day SMA ($728.63) but below the 50‑day SMA ($742.75), indicating a short‑term pull‑back within a neutral trend. The RSI of 47 and a bearish MACD histogram (‑1.81) suggest limited upside momentum, while volatility is elevated at nearly 40% over the past 30 days and a beta of 1.27 points to higher market sensitivity. Fundamentally, the company posts strong revenue growth of 19.7% YoY, a robust ROE of 38%, and solid cash generation with $1.31B operating cash flow, yet its current P/E of 25.7 is slightly below the industry average of 28.1, and the dividend yield is modest at 0.23% with a very low payout ratio of 3.5%. A DCF‑derived fair value of $672 is well under the market price, but analyst targets average $848, implying a perceived upside of roughly 20% per the upside/downside metric. Recent news highlights an updated valuation framework lifting the fair‑value estimate to about $869 and an upcoming investor event with senior leadership, which may catalyze renewed buying interest. Overall, the stock appears marginally overvalued by DCF standards, but the combination of strong earnings growth, low payout, and analyst optimism supports a cautious buy stance for the medium to long term.
Given the heightened volatility, bearish short‑term technical signals, and proximity to a support level around $685.5, a short‑term hold or modest exposure is prudent. However, the company’s balance sheet strength (debt to equity ~13, ample cash) and growth profile align with a longer‑term investment thesis, especially if the updated valuation narrative gains traction among investors.
Given the heightened volatility, bearish short‑term technical signals, and proximity to a support level around $685.5, a short‑term hold or modest exposure is prudent. However, the company’s balance sheet strength (debt to equity ~13, ample cash) and growth profile align with a longer‑term investment thesis, especially if the updated valuation narrative gains traction among investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD and neutral RSI indicate limited upside momentum
- Price near short‑term support at $685.5 with high 30‑day volatility
- Recent price decline of 4.3% suggests caution
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Revenue growth of 19.7% and strong ROE of 38% support earnings expansion
- Analyst target median of $848 implies ~20% upside
- Low dividend payout ratio preserves cash for reinvestment
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained cash generation and solid balance‑sheet capacity
- Infrastructure and construction tailwinds in the Industrials sector
- High return metrics (ROE, ROA) and modest leverage
Key Metrics & Analysis
Financial Health
Revenue Growth19.70%
Profit Margin7.49%
P/E Ratio25.7
ROE38.49%
ROA11.60%
Debt/Equity12.91
P/B Ratio8.8
Op. Cash Flow$1.3B
Free Cash Flow$991.1M
Industry P/E28.1
Technical Analysis
TrendNeutral
RSI47.3
Support$685.50
Resistance$775.86
MA 20$728.63
MA 50$742.75
MA 200$650.70
MACDBearish
VolumeIncreasing
Fear & Greed Index72.45
Valuation
Fair Value$672.10
Target Price$869.29
Upside/Downside20.11%
GradeOvervalued
TypeGrowth
Dividend Yield0.23%
Risk Assessment
Beta1.27
Volatility39.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.